Regulatory News:
Increased interest in NeuroVives (STO:NVP) product portfolio with cyclophilin inhibitors and energy regulators
This Interim Report is published in Swedish and English. In the event of any difference between the English version and the Swedish original, the Swedish version shall prevail.
Help employers find you! Check out all the jobs and post your resume.
